1
|
Burgess IF. Head lice: an inexpensive bioassay for use as guidance for healthcare workers monitoring treatment failures for insecticide resistance (1994-1999). Parasitol Res 2023; 122:425-433. [PMID: 36422709 DOI: 10.1007/s00436-022-07737-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2022] [Accepted: 11/14/2022] [Indexed: 11/25/2022]
Abstract
Head lice, Pediculus humanus capitis De Geer (Psocodea: Pediculidae) that failed to respond to pyrethroid insecticide-based treatment products were first identified in London and Cambridge, UK, in 1993 after which reports of treatment failure arose throughout the UK. There was a need amongst healthcare workers for a rapid detection method for resistance that could be used at the community level. A laboratory service was set up so that health professionals could send lice by overnight post for bioassay testing for resistance. In addition, test kits were provided so that testing could either be conducted on site or lice could be shipped to the laboratory on pre-treated test papers so that insecticide exposure could proceed while lice were in transit to the laboratory. Between 1994 and 1999, over 350 samples from 145 locations were tested and during this time populations of lice resistant to pyrethroids, malathion, and carbaryl were identified from all parts of the country, both urban and rural. In some areas, lice were only resistant to one of the insecticides available but in other places lice showed tolerance to all three insecticides used at the time.
Collapse
Affiliation(s)
- Ian F Burgess
- Medical Entomology Centre, Insect Research & Development Limited, 6 Quy Court, Colliers Lane, Stow-Cum-Quy, Cambridge, CB25 9AU, UK.
| |
Collapse
|
2
|
Nick JM, Sarpy NL. An analysis of data sources and study registries used in systematic reviews. Worldviews Evid Based Nurs 2022; 19:450-457. [PMID: 36380457 PMCID: PMC10099387 DOI: 10.1111/wvn.12614] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2022] [Revised: 08/24/2022] [Accepted: 08/27/2022] [Indexed: 11/17/2022]
Abstract
BACKGROUND Reporting standards for data sources in systematic reviews (SRs) have been developed, yet research shows varying compliance in the methods section. When this happens, replication of search results is difficult and creates ambiguous and biased data sources. AIMS This study captured author practices in choosing English and non-English-language databases, listing all the databases searched, and incorporating study registries as part of the search strategy. METHODS Using an analytic, cross-sectional, study design, volunteer data collectors (n = 107) searched one of two assigned English language platforms for SRs on specified health conditions. All the data sources found in the methods section of each SR were documented and analyzed for patterns using bibliographic techniques. RESULTS The final sample size of the SRs reviewed was N = 199. The mean number of data sources seen in the SRs was 3.9 (SD 2), with a range of 1-10. Eighteen records (9%) used a single data source to conduct the SRs. Four leading language platforms were seen in the SRs: English (100% of occurrences), up to 8% used Chinese data sources, and 4% included Spanish or Portuguese. The four most frequently used data sources were: (1) Medline (98%), (2) Embase (65%), (3) Cochrane Library (56%), and (4) Web of Science (33%). The percentage of SRs listing study registries was 30%. LINKING EVIDENCE TO ACTION Strategies to reduce bias and increase the rigor and reliability of SRs include comprehensive search practices by exploring non-English-language databases, using multiple data sources, and searching study registries. By following PRISMA-S guidelines to report data sources correctly, reproducibility can be accomplished.
Collapse
Affiliation(s)
- Jan M Nick
- Loma Linda University - School of Nursing, Loma Linda, California, USA
| | - Nancy L Sarpy
- Loma Linda University - School of Nursing, Loma Linda, California, USA
| |
Collapse
|
3
|
Burgess IF. Physically Acting Treatments for Head Lice—Can We Still Claim They Are ‘Resistance Proof’? Pharmaceutics 2022; 14:pharmaceutics14112430. [PMID: 36365251 PMCID: PMC9695066 DOI: 10.3390/pharmaceutics14112430] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2022] [Revised: 10/27/2022] [Accepted: 11/08/2022] [Indexed: 11/12/2022] Open
Abstract
Head lice worldwide have developed resistance to insecticides, prompting the introduction of a range of alternative treatments including plant extracts and natural and synthetic oils. Clinical studies of physically acting treatments showed them to be highly effective when first introduced, and a widely held, but unsubstantiated, belief is that lice are unlikely to develop resistance to them. However, this ignores possibilities for natural selection of traits enabling lice to survive exposure. More recent investigations of some physically acting products have shown reduced efficacy, suggesting either changes of behavior, physical structure, or physiology of some louse populations. In addition, the activity of surfactants and similar compounds, acting as solubilizing agents of insect cuticular lipids, can be compromised by the widespread use of toiletry products containing similar substances. Hitherto, most clinical investigations have provided “best case” data resulting from investigator application of treatments. In the few studies involving participant application, the effectiveness was reduced, suggesting that consumer use allows some insects to survive, which could then be selected for tolerance. Unlike neurotoxic insecticides, there is no straightforward method to test for the activity of physically acting chemicals other than by clinical investigations, which need to be rigorous to eliminate poorly effective products as a way of ensuring the continued effectiveness of those treatments that are successful in eliminating infestation.
Collapse
Affiliation(s)
- Ian F Burgess
- Medical Entomology Centre, Insect Research & Development Limited, 6 Quy Court, Colliers Lane, Stow-cum-Quy, Cambridge CB25 9AU, UK
| |
Collapse
|
4
|
Nolt D, Moore S, Yan AC, Melnick L. Head Lice. Pediatrics 2022; 150:189566. [PMID: 36156158 DOI: 10.1542/peds.2022-059282] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 07/27/2022] [Indexed: 11/24/2022] Open
Abstract
Head lice infestation is associated with limited morbidity but causes a high level of anxiety among caregivers of school-aged children and adolescents. Since the 2015 clinical report on head lice was published by the American Academy of Pediatrics, new medications have been approved, and an algorithm for management of affected patients is included. This revised clinical report clarifies current diagnosis and treatment protocols.
Collapse
Affiliation(s)
- Dawn Nolt
- Division of Infectious Diseases, Department of Pediatrics, Oregon Health and Science University, Portland, Oregon
| | - Scot Moore
- Department of Pediatrics, Indiana University Health, Bloomington, Indiana
| | - Albert C Yan
- Section of Dermatology, Children's Hospital of Philadelphia; Departments of Pediatrics and Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania
| | - Laura Melnick
- Department of Dermatology, Weill Cornell Medicine, New York, New York
| | | |
Collapse
|
5
|
Clay Nanotube Immobilization on Animal Hair for Sustained Anti-Lice Protection. Pharmaceutics 2021; 13:pharmaceutics13091477. [PMID: 34575552 PMCID: PMC8466176 DOI: 10.3390/pharmaceutics13091477] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/22/2021] [Revised: 09/04/2021] [Accepted: 09/09/2021] [Indexed: 01/20/2023] Open
Abstract
Topical administration of drugs is required for the treatment of parasitic diseases and insect infestations; therefore, fabrication of nanoscale drug carriers for effective insecticide topical delivery is needed. Here we report the enhanced immobilization of halloysite tubule nanoclay onto semiaquatic capybaras which have hydrophobic hair surfaces as compared to their close relatives, land-dwelling guinea pigs, and other agricultural livestock. The hair surface of mammals varies in hydrophobicity having a cortex surrounded by cuticles. Spontaneous 1-2 µm thick halloysite hair coverages on the semi-aquatic rodent capybara, non-aquatic rodent guinea pig, and farm goats were compared. The best coating was found for capybara due to the elevated 5 wt% wax content. As a result, we suggest hair pretreatment with diluted wax for enhanced nanoclay adsorption. The formation of a stable goat hair coverage with a 2-3 µm halloysite layer loaded with permethrin insecticide allowed for long-lasting anti-parasitic protection, enduring multiple rain wettings and washings. We expect that our technology will find applications in animal parasitosis protection and may be extended to prolonged human anti-lice treatment.
Collapse
|
6
|
Stevenson B, Tesfaye W, Christenson J, Mathew C, Abrha S, Peterson G, Samarawickrema I, Thomas J. Comparative efficacy and safety of interventions for treating head lice: a protocol for systematic review and network meta-analysis. BMJ Paediatr Open 2021; 5:e001129. [PMID: 34041368 PMCID: PMC8112437 DOI: 10.1136/bmjpo-2021-001129] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/15/2021] [Revised: 04/22/2021] [Accepted: 04/24/2021] [Indexed: 11/07/2022] Open
Abstract
Background Head lice infestation is a major public health problem around the globe. Its treatment is challenging due to product failures resulting from rapidly emerging resistance to existing treatments, incorrect treatment applications and misdiagnosis. Various head lice treatments with different mechanism of action have been developed and explored over the years, with limited report on systematic assessments of their efficacy and safety. This work aims to present a robust evidence summarising the interventions used in head lice. Method This is a systematic review and network meta-analysis which will be reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analyses statement for network meta-analyses. Selected databases, including PubMed, Embase, MEDLINE, Web of Science, CINAHL and Cochrane Central Register of Controlled Trials will be systematically searched for randomised controlled trials exploring head lice treatments. Searches will be limited to trials published in English from database inception till 2021. Grey literature will be identified through Open Grey, AHRQ, Grey Literature Report, Grey Matters, ClinicalTrials.gov, WHO International Clinical Trials Registry and International Standard Randomised Controlled Trials Number registry. Additional studies will be sought from reference lists of included studies. Study screening, selection, data extraction and assessment of methodological quality will be undertaken by two independent reviewers, with disagreements resolved via a third reviewer. The primary outcome measure is the relative risk of cure at 7 and 14 days postinitial treatment. Secondary outcome measures may include adverse drug events, ovicidal activity, treatment compliance and acceptability, and reinfestation. Information from direct and indirect evidence will be used to generate the effect sizes (relative risk) to compare the efficacy and safety of individual head lice treatments against a common comparator (placebo and/or permethrin). Risk of bias assessment will be undertaken by two independent reviewers using the Cochrane Risk of Bias tool and the certainty of evidence assessed using the Grading of Recommendations, Assessment, Development and Evaluations guideline for network meta-analysis. All quantitative analyses will be conducted using STATA V.16. Discussion The evidence generated from this systematic review and meta-analysis is intended for use in evidence-driven treatment of head lice infestations and will be instrumental in informing health professionals, public health practitioners and policy-makers. PROSPERO registration number CRD42017073375.
Collapse
Affiliation(s)
- Bill Stevenson
- Faculty of Health, University of Canberra, Canberra, Australian Capital Territory, Australia
| | - Wubshet Tesfaye
- Faculty of Health, University of Canberra, Canberra, Australian Capital Territory, Australia
| | - Julia Christenson
- Faculty of Health, University of Canberra, Canberra, Australian Capital Territory, Australia
| | - Cynthia Mathew
- Faculty of Health, University of Canberra, Canberra, Australian Capital Territory, Australia
| | - Solomon Abrha
- Faculty of Health, University of Canberra, Canberra, Australian Capital Territory, Australia
| | - Gregory Peterson
- Faculty of Health, University of Canberra, Canberra, Australian Capital Territory, Australia
- Pharmacy, University of Tasmania, Hobart, Tasmania, Australia
| | - Indira Samarawickrema
- Faculty of Health, University of Canberra, Canberra, Australian Capital Territory, Australia
| | - Jackson Thomas
- Faculty of Health, University of Canberra, Canberra, Australian Capital Territory, Australia
| |
Collapse
|
7
|
Huppertz HI, Iseke A, Heininger U, Grundhewer H, Knuf M, Korenke C, Müller A, von Both U. Evidenzbasierte Kontrolle der Pediculosis capitis und deren Sekundärprävention. Monatsschr Kinderheilkd 2021. [DOI: 10.1007/s00112-020-00987-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
8
|
Mumcuoglu KY, Pollack RJ, Reed DL, Barker SC, Gordon S, Toloza AC, Picollo MI, Taylan-Ozkan A, Chosidow O, Habedank B, Ibarra J, Meinking TL, Vander Stichele RH. International recommendations for an effective control of head louse infestations. Int J Dermatol 2020; 60:272-280. [PMID: 32767380 PMCID: PMC7984059 DOI: 10.1111/ijd.15096] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/09/2020] [Revised: 05/08/2020] [Accepted: 07/14/2020] [Indexed: 11/27/2022]
Abstract
Head louse infestations continue to be a concern of public health in most countries, including the most developed ones. The present recommendations are intended to inform and stress the role and impact of the different authorities, institutions, industry, and the public in the control of head lice in order to reduce the prevalence of this parasite. We encourage health authorities to pursue more effective methods to correctly identify such infestations, and evaluate existing and new pediculicides, medical devices, louse repellents, and louse- and nit-removal remedies. Pediculicides and medical devices must have verifiable claims in the instructions for use and should be tested periodically to document current levels of resistance by lice to the active ingredients and to the formulated products. Where the prevalence of lice is claimed to be epidemic, children should be periodically evaluated objectively to document the actual level of prevalence. Continuing education for health providers and the general population promises to correct misinformation regarding the biology, prevention, and management of lice. Parents should regularly inspect their children for head lice and treat as necessary. Health authorities are encouraged to eliminate policies and practices that rely upon school exclusion as a means to reduce incidence and prevalence, e.g., the 'no-nit' policy which lacks scientific justification, and are counterproductive to the health and welfare of children.
Collapse
Affiliation(s)
- Kosta Y Mumcuoglu
- Parasitology Unit, Department of Microbiology and Molecular Genetics, The Hebrew University-Hadassah Medical School, Jerusalem, Israel
| | - Richard J Pollack
- Harvard University, Environmental Health and Safety, Cambridge, MA, USA
| | - David L Reed
- Florida Museum of Natural History, University of Florida, Gainesville, FL, USA
| | - Stephen C Barker
- Discipline of Parasitology, School of Chemistry and Molecular Bioscience, University of Queensland, Brisbane, Australia
| | - Shirley Gordon
- Christine E. Lynn College of Nursing, Florida Atlantic University, Boca Raton, FL, USA
| | - Ariel C Toloza
- Centro de Investigaciones de Plagas e Insecticidas, Buenos Aires (CIPEIN-CITEFA/CONICET), Buenos Aires, Argentina
| | - Maria I Picollo
- Centro de Investigaciones de Plagas e Insecticidas, Buenos Aires (CIPEIN-CITEFA/CONICET), Buenos Aires, Argentina
| | - Aysegul Taylan-Ozkan
- Department of Medical Microbiology, Faculty of Medicine, Hitit University, Corum, Turkey.,Near-East University, Nicosia, Cyprus
| | - Olivier Chosidow
- Department of Dermatology, AP-HP, Hôpital Henri Mondor, UPEC, Créteil, Paris, France
| | - Birgit Habedank
- Umweltbundesamt - German Environment Agency, Berlin, Germany
| | | | | | | |
Collapse
|
9
|
Ectoparasites. J Am Acad Dermatol 2020; 82:551-569. [DOI: 10.1016/j.jaad.2019.05.110] [Citation(s) in RCA: 30] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2019] [Revised: 05/16/2019] [Accepted: 05/31/2019] [Indexed: 12/18/2022]
|
10
|
Kalari H, Soltani A, Azizi K, Faramarzi H, Moemenbellah-Fard MD. Comparative efficacy of three pediculicides to treat head lice infestation in primary school girls: a randomised controlled assessor blind trial in rural Iran. BMC DERMATOLOGY 2019; 19:13. [PMID: 31510998 PMCID: PMC6739928 DOI: 10.1186/s12895-019-0093-5] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/02/2019] [Accepted: 08/19/2019] [Indexed: 11/24/2022]
Abstract
Background Head lice infestation (Pediculosis) is one of the most important health challenges particularly in primary school-aged children. It is often present among 6–11-year-old students in various tropical and temperate regions of the world. The aim of this study was to examine epidemiologic indices and comparative analysis of two pyrethroid-based and one non-chemical pediculicide products on head lice treatment of primary school girls in a rural setting of Fars province, south Iran, as part of a randomized controlled assessor blind trial. Methods Before treatment, infested students were screened using plastic detection combs to find live head lice. Three independent parallel groups, each with about 25 participants (#77) were eventually twice with a week apart treated with either 1% permethrin, 0.2% parasidose (d-phenothrin) or 4% dimeticone lotion preparations. In each case, a questionnaire form was completed on epidemiologic factors. Data were registered after a fortnight from primary scalp treatment and re-inspection on days 2, 6, 9 and 14. Data analyses were performed using Chi-square test with a P-value < 0.05 being taken as statistically significant. Results From 3728 inspected students, 87 (2.33%) girls were infested with head lice, Pediculus humanus capitis De Geer, 1778. Ten students dropped out pertaining to exclusion criteria. No significant correlation was found between head lice infestation level and hair length, hair style, itching, nationality, age, settlement site and baths; but there was a significant relationship between age and hair style (P = 0.027). The efficacy values on each of the above re-inspection days from each of the three treatments were 81, 74, 70 and 63% for permethrin; 83, 92, 100 and 100% for dimeticone; and 96, 88, 96 and 92% for d-phenothrin; respectively. A quartile difference in efficacy of permethrin relative to dimeticone on day 14 represented the scale of head lice resistance to permethrin treatment. There were significant statistical differences in case re-inspection days 9 (P = 0.008) and 14 (P = 0.003) post treatment. Only two dropout cases, one non-compliant and the other lost before the second-week treatment, from permethrin trial were observed following two applications a week apart. Conclusions Dimeticone lotion had the fullest efficacy (100%) among all treatments. This high cure rate was attributed to the low level of infestation and the extent of patients’ involvement. Parasidose swiftly ameliorated the infested cases by the second day since initial treatment. Female third grade students were the most infested cohort. Trial registration Current Controlled Trials- IRCT2016041627408N1, Dated: 21-08-2017.
Collapse
Affiliation(s)
- Hadi Kalari
- Department of Medical Entomology and Vector Control, School of Health, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Aboozar Soltani
- Research Center for Health Sciences, Institute of Health, Department of Medical Entomology and Vector Control, School of Health, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Kourosh Azizi
- Research Center for Health Sciences, Institute of Health, Department of Medical Entomology and Vector Control, School of Health, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Hossein Faramarzi
- Department of Community Medicine, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Mohammad Djaefar Moemenbellah-Fard
- Research Center for Health Sciences, Institute of Health, Department of Medical Entomology and Vector Control, School of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
| |
Collapse
|
11
|
Koch E, Clark JM, Cohen B, Meinking TL, Ryan WG, Stevenson A, Yetman R, Yoon KS. Management of Head Louse Infestations in the United States-A Literature Review. Pediatr Dermatol 2016; 33:466-72. [PMID: 27595869 DOI: 10.1111/pde.12982] [Citation(s) in RCA: 33] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
UNLABELLED Head lice are a source of scalp irritation, social disruption, and loss of school time. Health care providers need authoritative information to help avoid the costs and risks of ineffective treatment. A review was completed to provide relevant information on infestation treatments available in the United States. Three major biomedical databases were searched from 1985, when current products were first available, to 2014, focusing on U.S. REPORTS A total of 579 references remained after duplicates were removed. A search of the U.S. Food and Drug Administration website and labels of approved products were reviewed. A marked decline in the effectiveness of permethrin and synergized pyrethrins was found, probably because of resistance arising from widespread and indiscriminate use, and the emergence of knockdown resistance mutations. The potential toxicity of lindane in the setting of readily available, safer, and more effective alternatives, should limit its use. Prescription products shown to be safe and effective with a single application, without nit combing, are topical ivermectin, malathion, and spinosad, whereas benzyl alcohol requires two applications. Home remedies such as mayonnaise, and essential oils, have not been demonstrated to be safe or effective, and may carry potential for severe adverse events. The high risk of failure of over-the-counter treatments in eliminating head louse infestations drives a need for health care provider recognition of the limitations of current treatments and for judicious use of treatments that remain effective.
Collapse
Affiliation(s)
- Ellen Koch
- Division of Pediatric Dermatology, Johns Hopkins Medicine, Baltimore, Maryland
| | - John Marshall Clark
- Department of Veterinary and Animal Sciences, University of Massachusetts, Amherst, Massachusetts
| | - Bernard Cohen
- Division of Pediatric Dermatology, Johns Hopkins Medicine, Baltimore, Maryland
| | | | | | | | - Robert Yetman
- University of Texas-Houston Medical School, Houston, Texas
| | - Kyong Sup Yoon
- Department of Biological Sciences and Environmental Sciences Program, Southern Illinois University-Edwardsville, Edwardsville, Illinois
| |
Collapse
|
12
|
Sangaré AK, Doumbo OK, Raoult D. Management and Treatment of Human Lice. BIOMED RESEARCH INTERNATIONAL 2016; 2016:8962685. [PMID: 27529073 PMCID: PMC4978820 DOI: 10.1155/2016/8962685] [Citation(s) in RCA: 33] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/11/2016] [Revised: 04/17/2016] [Accepted: 06/16/2016] [Indexed: 12/18/2022]
Abstract
Of the three lice (head, body, and pubic louse) that infest humans, the body louse is the species involved in epidemics of louse-borne typhus, trench fever, and relapsing fever, but all the three cause pediculosis. Their infestations occur today in many countries despite great efforts to maintain high standards of public health. In this review, literature searches were performed through PubMed, Medline, Google Scholar, and EBSCOhost, with key search words of "Pediculus humanus", "lice infestation", "pediculosis", and "treatment"; and controlled clinical trials were viewed with great interest. Removing lice by hand or with a lice comb, heating infested clothing, and shaving the scalp were some of the oldest methods of controlling human lice. Despite the introduction of other resources including cresol, naphthalene, sulfur, mercury, vinegar, petroleum, and insecticides, the numbers of lice infestation cases and resistance have increased. To date, viable alternative treatments to replace insecticides have been developed experimentally in vitro. Today, the development of new treatment strategies such as symbiotic treatment and synergistic treatment (antibiotics + ivermectin) in vitro has proved effective and is promising. Here, we present an overview on managing and treating human lice and highlight new strategies to more effectively fight pediculosis and prevent resistance.
Collapse
Affiliation(s)
- Abdoul Karim Sangaré
- Research Unit on Emerging Infectious and Tropical Diseases (URMITE), UMR CNRS 7278, IRD 198, INSERM 1095, Faculty of Medicine, Aix-Marseille University, 27 boulevard Jean Moulin, 13005 Marseille, France
- Epidemiology Department of Parasitic Diseases, Faculty of Medicine and Odonto-Stomatology, Faculty of Pharmacy (MRTC/DEAP/FMOS-FAPH) UMI3189, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| | - Ogobara K. Doumbo
- Epidemiology Department of Parasitic Diseases, Faculty of Medicine and Odonto-Stomatology, Faculty of Pharmacy (MRTC/DEAP/FMOS-FAPH) UMI3189, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| | - Didier Raoult
- Research Unit on Emerging Infectious and Tropical Diseases (URMITE), UMR CNRS 7278, IRD 198, INSERM 1095, Faculty of Medicine, Aix-Marseille University, 27 boulevard Jean Moulin, 13005 Marseille, France
| |
Collapse
|
13
|
Punareewattana K, Smith BJ, Blaylock BL, Robertson JL, Gogal RM, Prater MR, Longstreth J, Snodgrass HL, Holladay SD. Topical Permethrin Exposure Causes Thymic Atrophy and Persistent Inhibition of the Contact Hypersensitivity Response in C57BI/6 Mice. Int J Toxicol 2016. [DOI: 10.1080/109158100750058730] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/16/2022]
Abstract
Permethrin was applied to the shaved dorsal interscapular region of female C57B1/6 mice at doses of 0.5 or 1.5 θ 1/day in corn oil and neat 5.0 θ 1/day. These doses corresponded to approximately 22, 66, and 220 mg/kg/day topical permethrin. Mice were exposed in this manner either daily for 10 or 30 consecutive days, or every other day for 7 or 14 exposures. Body weight was not affected by any of the treatment regimens. However, thymic weight was decreased and splenic weight was increased by 1.5 or 5.0 θ1 permethrin/day, 2 days after termination of 10 consecutive days of topical chemical exposure. Cell surface antigen expression did not change in any treatment group on thymocytes (CD4, CD8), splenocytes (CD45R, Thy 1.2), or bone marrow cells (CD45, CD45R). A persistent, dose-related inhibition of the contact hypersensitivity (CH) response occurred in mice at all exposure levels of permethrin tested.
Collapse
Affiliation(s)
- Korawuth Punareewattana
- Department of Biomedical Sciences and Pathobiology, Virginia-Maryland Regional College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, Virginia, USA
| | - Bonnie J. Smith
- Department of Biomedical Sciences and Pathobiology, Virginia-Maryland Regional College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, Virginia, USA
| | - Benny L. Blaylock
- College of Pharmacy and Health Sciences, University of Louisiana at Monroe, Monroe, Louisiana, USA
| | - John L. Robertson
- Department of Biomedical Sciences and Pathobiology, Virginia-Maryland Regional College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, Virginia, USA
| | - Robert M. Gogal
- Department of Biomedical Sciences and Pathobiology, Virginia-Maryland Regional College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, Virginia, USA
| | - M. Renee Prater
- Department of Biomedical Sciences and Pathobiology, Virginia-Maryland Regional College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, Virginia, USA
| | - Janice Longstreth
- The Institute for Global Risk Research, LLC, Bethesda, Maryland, USA
| | - Hubert L. Snodgrass
- U.S. Army Center for Health Promotion and Preventive Medicine, Health Effects Research Program, Aberdeen Proving Ground, Maryland, USA
| | - Steven D. Holladay
- Department of Biomedical Sciences and Pathobiology, Virginia-Maryland Regional College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, Virginia, USA
| |
Collapse
|
14
|
Abstract
Head lice infestation is associated with limited morbidity but causes a high level of anxiety among parents of school-aged children. Since the 2010 clinical report on head lice was published by the American Academy of Pediatrics, newer medications have been approved for the treatment of head lice. This revised clinical report clarifies current diagnosis and treatment protocols and provides guidance for the management of children with head lice in the school setting.
Collapse
|
15
|
Combescot-Lang C, Vander Stichele RH, Toubate B, Veirron E, Mumcuoglu KY. Ex vivo effectiveness of French over-the-counter products against head lice (Pediculus humanus capitis De Geer, 1778). Parasitol Res 2015; 114:1779-92. [PMID: 25716822 DOI: 10.1007/s00436-015-4363-9] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/12/2014] [Accepted: 01/30/2015] [Indexed: 11/25/2022]
Abstract
Head lice infestation is still a public health problem worldwide, with an intracountry and intercountry prevalence variation of 0.7 to 59%. There is a large variety of over-the-counter anti-louse products, but their efficacy is not always well assessed. Our objective was to test the pediculicidal and ovicidal efficacy of 21 over-the-counter head louse products, available in France during the period of 2008 to 2012. We tested children living in Tours City in central France and visiting preschools, primary schools, kindergarten, camps, and child care facilities, as well as children in their family houses, and were examined for the presence of lice. The products were collected from randomly selected pharmacies by covert investigators and then tested in the laboratory on an ex vivo sample of head lice and their eggs, collected from the hair of infested children. Living lice and unharmed eggs were collected from the scalps of 3-12 years old. The laboratory conditions for ex vivo testing mimicked the manufacturers' instructions for exposure time and application method. In 21 runs, 3919 living lice and 4321 undamaged living eggs were collected from the scalp of over 400 children. The 21 products were classified in three groups: 6 products in a group of potentially 100% pediculicidal activity and potentially 100% ovicidal activity, 8 products in a group of potentially 100% pediculicidal activity but insufficient ovicidal activity (including 2 products with claims of single application treatment), and 7 products in a group of insufficient pediculicidal activity and ovicidal activity. The pharmaceutical market for head lice products in France is swamped with poorly tested and ineffective products. Rigorous efficacy testing preregistration and periodic screening and testing of effectiveness in the post-registration period should be endorsed by the health authorities.
Collapse
|
16
|
Kettel MJ, Schaefer K, Groll J, Moeller M. Nanogels with high active β-cyclodextrin content as physical coating system with sustained release properties. ACS APPLIED MATERIALS & INTERFACES 2014; 6:2300-2311. [PMID: 24533699 DOI: 10.1021/am404126r] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
We present the application of nanogels with high functional β-cyclodextrin (β-CD) content as new and versatile method for the modification and protection of textiles. The complexation potential of covalently embedded β-CD in nanogels is demonstrated for the common insecticide permethrin in aqueous environment. It is shown that permethrin containing β-CD nanogels can be applied easily, homogeneously and safely on keratin fibers like wool fabrics and human hairs. The permethrin concentration on fibers is directly controlled by the permethrin content in nanogels. We tested the permanence of permethrin on treated fibers with regard to washing and UV fastness. Our results show that permethrin complexed in nanogels is removed from the textile during washing, but that the complexation of permethrin by β-CD domains in the nanogels protects the active ingredient from UV degradation. Bioassay tests against the larvae of Tineola bisselliella and Anthrenocerus australis show that the activity of the ingredients does not decrease after complexation in β-CD gels and it results in protection of the wool fibers against degradation by the insect larvae.
Collapse
Affiliation(s)
- Markus J Kettel
- DWI-Leibniz Institute for Interactive Materials and Institute of Technical and Macromolecular Chemistry, RWTH Aachen University , Forckenbeckstr. 50, 52056 Aachen, Germany
| | | | | | | |
Collapse
|
17
|
|
18
|
Do-Pham G, Le Cleach L, Giraudeau B, Maruani A, Chosidow O, Ravaud P. Designing randomized-controlled trials to improve head-louse treatment: systematic review using a vignette-based method. J Invest Dermatol 2013; 134:628-634. [PMID: 24121401 DOI: 10.1038/jid.2013.414] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2013] [Revised: 08/19/2013] [Accepted: 09/02/2013] [Indexed: 12/20/2022]
Abstract
Head-louse infestation remains a public health problem. Despite published randomized-controlled trials, no consensus-based clinical practice guidelines for its management emerged because of the heterogeneity of trial methodologies. Our study was undertaken to attempt to find an optimal trial framework: minimizing the risk of bias, while taking feasibility into account. To do so, we used the vignette-based method. A systematic review first identified trials on head-louse infestation; 49 were selected and their methodological constraints assessed. Methodological features were extracted and combined by arborescence to generate a broad spectrum of potential designs, called vignettes, yielding 357 vignettes. A panel of 48 experts then rated one-on-one comparisons of those vignettes to obtain a ranking of the designs. Methodological items retained for vignette generation were income level of the population, types of treatments compared, randomization unit, blinding, treatment-administration site, diagnosis method and criteria, and primary outcome measure. The expert panel selected vignettes with cluster randomization, centralized treatment administration, and blinding of the outcome assessor. The vignette method identified optimal designs to standardize future head-louse treatment trials, thereby obtaining valid conclusions and comparable data from future trials, and appears to be a reliable way to generate evidence-based guidelines.
Collapse
Affiliation(s)
- Giao Do-Pham
- Department of Dermatology, Groupe Hospitalier Henri Mondor, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France; INSERM U738, Paris, France
| | - Laurence Le Cleach
- Department of Dermatology, Groupe Hospitalier Henri Mondor, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France
| | - Bruno Giraudeau
- INSERM U738, Paris, France; Centre d'Investigation Clinique 202, INSERM Tours, Centre Hospitalier Régional Universitaire de Tours, Université François-Rabelais, Tours, France
| | - Annabel Maruani
- Department of Dermatology, Centre Hospitalier Régional Universitaire de Tours, Université François-Rabelais, Tours, France
| | - Olivier Chosidow
- Department of Dermatology, Groupe Hospitalier Henri Mondor, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France; Université Paris-Est Créteil, Créteil, France; French Cochrane Centre, Paris, France; Centre d'Investigation Clinique 006, INSERM Créteil, France
| | - Philippe Ravaud
- INSERM U738, Paris, France; Centre d'Epidémiologie Clinique, Hôpital Hôtel-Dieu, APHP Paris, France; Université Paris Descartes-Sorbonne Paris Cité, Paris, France; EHESP School of Public Health, Paris, France; Department of Epidemiology, Columbia University Mailman School of Public Health, New York, New York, USA.
| |
Collapse
|
19
|
Kiran B, Kareem SA, Illamani V, Chitralekha S. Case of Phthiriasis palpebrarum with blepheroconjunctivitis. Indian J Med Microbiol 2013; 30:354-6. [PMID: 22885208 DOI: 10.4103/0255-0857.99504] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
A 70-year-old woman came to ophthalmology outpatient department with complaints of repeated episodes of itching, redness and watering in both eyes of 3 months duration. She was treated with antibiotics elsewhere but had no improvement. Slit lamp examination showed lice and nits anchored to the eyelashes. Light microscopic examination of the matted eye lashes and crusts further helped in identification of the ectoparasites as Phthirus pubis (Pubic louse or Crab louse) with typical morphology.
Collapse
Affiliation(s)
- B Kiran
- Department of Microbiology, Sree Balaji Medical College and Hospital, Chrompet, India
| | | | | | | |
Collapse
|
20
|
Abstract
Lindane is an organochloride pesticide, first introduced as a scabicide for human use in the 1950s. Because of its low cost and efficacy, it quickly became a first-line treatment for scabies and head lice, but not long after its use became widespread, its safety was called into question, primarily regarding its neurotoxic effects. We intend to show through review of the literature and databases that lindane has been associated with numerous severe and fatal adverse reactions. This review will summarize 67 cases of adverse reactions and deaths associated with the medical use of lindane. Many of the most serious events and fatalities occurred in pediatric and geriatric populations. We concede that toxicity frequently arises from misuse, but labeled usage of lindane caused 43% of the serious adverse reactions of this review. Moreover, the numerous instances of lindane misuse elucidate the importance of clear labeling and instructions, especially with a product with a narrow therapeutic index. Therefore, this report attempts to elucidate the dangers of lindane as a medical treatment for scabies and head lice by providing a comprehensive review of all documented adverse drug reactions since its introduction.
Collapse
Affiliation(s)
- Katherine Nolan
- Department of Dermatology, Mount Sinai School of Medicine, New York, NY 10029, USA.
| | | | | |
Collapse
|
21
|
van der Wouden JC, Klootwijk T, Le Cleach L, Do G, Vander Stichele R, Knuistingh Neven A, Eekhof JAH. Interventions for treating head lice. Hippokratia 2011. [DOI: 10.1002/14651858.cd009321] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
| | - Tim Klootwijk
- Erasmus Medical Center; Department of General Practice; PO Box 2040 Rotterdam Netherlands 3000 CA
| | - Laurence Le Cleach
- Hospital Henri Mondor; Department of Dermatologie; 51 avenue du Général de Lattre de Tassigny Créteil France 94010
| | - Giao Do
- Hospital Henri Mondor; Department of Dermatologie; 51 avenue du Général de Lattre de Tassigny Créteil France 94010
| | - Robert Vander Stichele
- Ghent University; Heymans Institute of Clinical Pharmacology; De Pintelaan 185 Ghent Belgium B-9000
| | - Arie Knuistingh Neven
- Leiden University Medical Center; Department of Public Health and Primary Care; PO Box 9600 Leiden Netherlands 2300 RC
| | - Just AH Eekhof
- Leiden University Medical Center; Department of Public Health and Primary Care; PO Box 9600 Leiden Netherlands 2300 RC
| |
Collapse
|
22
|
Laguna MF, Laguna MF, Risau-Gusman S. Of lice and math: using models to understand and control populations of head lice. PLoS One 2011; 6:e21848. [PMID: 21799752 PMCID: PMC3140471 DOI: 10.1371/journal.pone.0021848] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2011] [Accepted: 06/07/2011] [Indexed: 12/24/2022] Open
Abstract
In this paper we use detailed data about the biology of the head louse (pediculus humanus capitis) to build a model of the evolution of head lice colonies. Using theory and computer simulations, we show that the model can be used to assess the impact of the various strategies usually applied to eradicate head lice, both conscious (treatments) and unconscious (grooming). In the case of treatments, we study the difference in performance that arises when they are applied in systematic and non-systematic ways. Using some reasonable simplifying assumptions (as random mixing of human groups and the same mobility for all life stages of head lice other than eggs) we model the contagion of pediculosis using only one additional parameter. It is shown that this parameter can be tuned to obtain collective infestations whose characteristics are compatible with what is given in the literature on real infestations. We analyze two scenarios: One where group members begin treatment when a similar number of lice are present in each head, and another where there is one individual who starts treatment with a much larger threshold ("superspreader"). For both cases we assess the impact of several collective strategies of treatment.
Collapse
Affiliation(s)
- María Fabiana Laguna
- Consejo Nacional de Investigaciones Cientficas y Técnicas and Centro Atómico Bariloche, Bariloche, Río Negro, Argentina.
| | | | | |
Collapse
|
23
|
Burgess IF. Head lice. BMJ CLINICAL EVIDENCE 2011; 2011:1703. [PMID: 21575285 PMCID: PMC3275145] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
INTRODUCTION Head lice can only be diagnosed by finding live lice, as eggs take 7 days to hatch and may appear viable for weeks after death of the egg. Infestation may be more likely in school children, with risks increased in children with more siblings, longer hair, and of lower socioeconomic group. METHODS AND OUTCOMES We conducted a systematic review and aimed to answer the following clinical question: What are the effects of treatments for head lice? We searched: Medline, Embase, The Cochrane Library, and other important databases up to June 2010 (Clinical Evidence reviews are updated periodically, please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA). RESULTS We found 26 systematic reviews, RCTs, or observational studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions. CONCLUSIONS In this systematic review, we present information relating to the effectiveness and safety of the following interventions: benzyl alcohol, dimeticone, herbal and essential oils, insecticide combinations, isopropyl myristate, ivermectin, lindane, malathion, mechanical removal by combing ("bug busting"), oral trimethoprim-sulfamethoxazole (co-trimoxazole, TMP-SMX), permethrin, phenothrin, pyrethrum, and spinosad.
Collapse
Affiliation(s)
- Ian F Burgess
- Insect Research & Development Limited, Cambridge, UK
| |
Collapse
|
24
|
Abstract
Head lice infestation is associated with limited morbidity but causes a high level of anxiety among parents of school-aged children. Since the 2002 clinical report on head lice was published by the American Academy of Pediatrics, patterns of resistance to products available over-the-counter and by prescription have changed, and additional mechanical means of removing head lice have been explored. This revised clinical report clarifies current diagnosis and treatment protocols and provides guidance for the management of children with head lice in the school setting.
Collapse
|
25
|
Chosidow O, Giraudeau B, Cottrell J, Izri A, Hofmann R, Mann SG, Burgess I. Oral ivermectin versus malathion lotion for difficult-to-treat head lice. N Engl J Med 2010; 362:896-905. [PMID: 20220184 DOI: 10.1056/nejmoa0905471] [Citation(s) in RCA: 156] [Impact Index Per Article: 11.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
BACKGROUND Head-lice infestation is prevalent worldwide, especially in children 3 to 11 years old. Topical insecticides (i.e., pyrethroids and malathion) used as a lotion, applied twice at an interval of 7 to 11 days, are typically used for treatment. Resistance of lice to insecticides, particularly pyrethroids, results in treatment failure. The efficacy of alternative agents is controversial. METHODS We conducted a multicenter, cluster-randomized, double-blind, double-dummy, controlled trial comparing oral ivermectin (at a dose of 400 microg per kilogram of body weight) with 0.5% malathion lotion, each given on days 1 and 8, for patients with live lice not eradicated by topical insecticide used 2 to 6 weeks before enrollment. The cluster was defined as the household. Infestation was confirmed and monitored by means of fine-toothed combing. Patients were at least 2 years of age and weighed at least 15 kg; all were treated at the study sites. The primary end point was the absence of head lice on day 15. RESULTS A total of 812 patients from 376 households were randomly assigned to receive either ivermectin or malathion. In the intention-to-treat population, 95.2% of patients receiving ivermectin were lice-free on day 15, as compared with 85.0% of those receiving malathion (absolute difference, 10.2 percentage points; 95% confidence interval [CI], 4.6 to 15.7; P<0.001). In the per-protocol population, 97.1% of patients in the ivermectin group were lice-free on day 15, as compared with 89.8% of those in the malathion group (absolute difference, 7.3 percentage points; 95% CI, 2.8 to 11.8; P=0.002). There were no significant differences in the frequencies of adverse events between the two treatment groups. CONCLUSIONS For difficult-to-treat head-lice infestation, oral ivermectin, given twice at a 7-day interval, had superior efficacy as compared with topical 0.5% malathion lotion, a finding that suggests that it could be an alternative treatment. (ClinicalTrials.gov number, NCT00819520.)
Collapse
Affiliation(s)
- Olivier Chosidow
- Université Pierre et Marie Curie Paris 6 and Assistance Publique-Hôpitaux de Paris, Paris, France.
| | | | | | | | | | | | | |
Collapse
|
26
|
Moss P, Beeching NJ. Arthropods and ectoparasites. Infect Dis (Lond) 2010. [DOI: 10.1016/b978-0-323-04579-7.00011-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
27
|
Burgess IF. Head lice. BMJ CLINICAL EVIDENCE 2009; 2009:1703. [PMID: 19445766 PMCID: PMC2907830] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
INTRODUCTION Head lice can only be diagnosed by finding live lice, as eggs take 7 days to hatch and may appear viable for weeks after death of the egg. Infestation may be more likely in school children, with risks increased in children with more siblings, longer hair, and of lower socioeconomic group. METHODS AND OUTCOMES We conducted a systematic review and aimed to answer the following clinical question: What are the effects of treatments for head lice? We searched: Medline, Embase, The Cochrane Library, and other important databases up to June 2008 (Clinical Evidence reviews are updated periodically, please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA). RESULTS We found 15 systematic reviews, RCTs, or observational studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions. CONCLUSIONS In this systematic review we present information relating to the effectiveness and safety of the following interventions: dimeticone, herbal and essential oils, insecticide combinations, lindane, malathion, mechanical removal by combing ('bug busting'), oral trimethoprim-sulfamethoxazone (co-trimoxazole, TMP-SMX), permethrin, phenothrin, and pyrethrum.
Collapse
Affiliation(s)
- Ian F Burgess
- Insect Research & Development Limited, Cambridge, UK
| |
Collapse
|
28
|
Gur I, Schneeweiss R. Head lice treatments and school policies in the US in an era of emerging resistance: a cost-effectiveness analysis. PHARMACOECONOMICS 2009; 27:725-734. [PMID: 19757866 DOI: 10.2165/11313740-000000000-00000] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
BACKGROUND Head lice are a common infection in school-age children worldwide. Several authorities in the US have recommended different treatments and school policies in order to control this disease. Recent concerns of emerging lice resistance worldwide raise the necessity to reassess the current recommendations. OBJECTIVES To perform a cost-effectiveness analysis (from the US caregiver perspective) of three head lice treatments commonly used in the US, permethrin 1%, malathion 0.5% and the lice comb, in order to evaluate the cost effectiveness of different treatments in the current era, and to explore the effect of different factors in this analysis. METHODS We used a decision-tree model to represent the costs and effectiveness of the different treatment strategies. A patient/caregiver perspective was applied, with a time horizon of 2 weeks. Probabilities of treatment success or failure of the three treatments were based on the literature. Effectiveness was measured as the successful eradication of head lice, and costs - including the costs of the treatment, the physician co-pay and the costs of days out of school - were calculated. One-way and multi-way analyses were performed using decision analysis software (Treeage Pro Healthcare 2008). RESULTS Combing was dominated by permethrin 1%. The incremental cost-effectiveness ratio of malathion 0.5% versus permethrin 1% was $US161.75 per cure. For caregivers whose willingness to pay is <$US161.75 per cure, permethrin 1% is the most cost-effective option. For those with a willingness to pay of > or =$US161.75 per cure malathion 1% may offer the highest net monetary benefit. Twenty percent of the uncertainty in the model is due to variation in permethrin 1% resistance, and approximately 73% of the total variability of the model is attributed to the number of days the student has to be out of school because of the school's policy. CONCLUSIONS Our study suggests that permethrin 1% was the most cost-effective treatment for those with a willingness to pay of <$US162 per cure. Sensitivity of lice to permethrin and the specific school head lice policy had major effects on the model. Thus, informing communities in a given geographical area about the degree of head lice resistance and sensitivity is necessary in order for the public to make a rational decision regarding treatment. Schools' head lice policies have a major effect on the cost of head lice treatments.
Collapse
Affiliation(s)
- Itzhak Gur
- Department of Family Medicine, University of Washington, Seattle, Washington, USA.
| | | |
Collapse
|
29
|
Heukelbach J, Pilger D, Oliveira FA, Khakban A, Ariza L, Feldmeier H. A highly efficacious pediculicide based on dimeticone: randomized observer blinded comparative trial. BMC Infect Dis 2008; 8:115. [PMID: 18783606 PMCID: PMC2553415 DOI: 10.1186/1471-2334-8-115] [Citation(s) in RCA: 47] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2008] [Accepted: 09/10/2008] [Indexed: 11/16/2022] Open
Abstract
Background Infestation with the human head louse (Pediculus humanus capitis) occurs worldwide. Existing treatment options are limited, and reports of resistance to commonly used pediculicides have been increasing. In this trial we assessed the efficacy of a product containing a high (92%) concentration of the silicone oil dimeticone (identical in composition to NYDA®), as compared to a 1% permethrin lotion. Methods Randomized, controlled, observer blinded clinical trial. Participants were recruited from a poor urban neighbourhood in Brazil where pediculosis capitis was highly prevalent. To minimize reinfestation during the trial, participants (145 children aged 5–15 years with head lice infestations) were transferred to a holiday resort outside the endemic area for a period of 9 days. Two applications of dimeticone or 1% permethrin were done, seven days apart. Outcome measures were defined as cure (absence of vital head lice) after first application and before and after second applications, degree of itching, cosmetic acceptability, and clinical pathology. Results Overall cure rates were: day 2 – dimeticone 94.5% (95% CI: 86.6% – 98.5%) and permethrin 66.7% (95% CI: 54.6% – 77.3%; p < 0.0001); day 7 – dimeticone 64.4% (95% CI: 53.3% – 75.3%) and permethrin 59.7% (95% CI: 47.5% – 71.1%; p = 0.5); day 9 – dimeticone 97.2% (95% CI: 90.3% – 99.7%) and permethrin 67.6% (95% CI: 55.4%-78.2%); p < 0.0001). Itching was reduced similarly in both groups. Cosmetic acceptability was significantly better in the dimeticone group as compared to the permethrin group (p = 0.01). Two mild product-related incidents occurred in the dimeticone group. Conclusion The dimeticone product is a safe and highly efficacious pediculicide. Due to its physical mode of action (interruption of the lice's oxygen supply of the central nervous system), development of resistance is unlikely. Trial registration Current Controlled Trials ISRCTN15117709.
Collapse
Affiliation(s)
- Jorg Heukelbach
- Department of Community Health, School of Medicine, Federal University of Ceará, Fortaleza, Brazil.
| | | | | | | | | | | |
Collapse
|
30
|
Plastow L, Luthra M, Powell R, Wright J, Russell D, Marshall MN. Head lice infestation: bug busting vs. traditional treatment. J Clin Nurs 2008. [DOI: 10.1111/j.1365-2702.2001.00541.x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
31
|
Diaz JH. The Global Epidemiology, Public Health Outcomes, Management, and Prevention of Re-Emerging Ectoparasitic Diseases. Trop Med Health 2008. [DOI: 10.2149/tmh.36.1] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022] Open
|
32
|
Abstract
BACKGROUND Infection with head lice is a widespread condition in developed and developing countries. Infection occurs most commonly in children, but also affects adults. If left untreated the condition can become intensely irritating and skin infections may occur if the bites are scratched. OBJECTIVES The aim of this review was to assess the effects of interventions for head lice. SEARCH STRATEGY Cochrane Infectious Diseases Group specialized trials register (July 2002); The Cochrane Central Register of Controlled Trials (The Cochrane Library Issue 2, 2002); MEDLINE and TOXLINE (1966 to July 2002); EMBASE (1980 to May 2002); LILACS (July 2002); Science Citation Index (1981 to July 2002); BIOSIS (1985 to July 2002); reference lists of relevant articles; pharmaceutical companies producing pediculicides (published and unpublished trials); UK and US Regulatory Authorities. SELECTION CRITERIA Randomised trials (published and unpublished) or trials using alternate allocation were sought which compared pediculicides with the same and different formulations of other pediculicides, and pediculicides with physical methods. DATA COLLECTION AND ANALYSIS Of the 71 identified studies, only four met the inclusion criteria. Two reviewers independently assessed trial quality. One reviewer extracted the data. MAIN RESULTS We found no evidence that any one pediculicide has greater effect than another. The two studies comparing malathion and permethrin with their respective vehicles showed a higher cure rate for the active ingredient than the vehicle. Another study comparing synergised pyrethrins with permethrin showed their effects to be equivalent. A comparative trial of malathion lotion vs combing, showed combing to be ineffective for the cureative treatment of head lice infection. Adverse effects were reported in a number of trials and were all minor, although reporting quality varied between trials. AUTHORS' CONCLUSIONS Permethrin, synergised pyrethrin and malathion were effective in the treatment of head lice. However, the emergence of drug resistance since these trials were conducted means there is no direct contemporary evidence of the comparative effectiveness of these products. The 'best' choice will now depend on local resistance patterns. Physical treatment methods(BugBusting) were shown ot be ineffective to treat head lice. No evidence exists regarding other chemical control methods such as the use of herbal treatments, when used in the curative treatment of head lice. Future trials should take into account the methodological recommendations that arise from this review.
Collapse
Affiliation(s)
- C S Dodd
- Cardiff Univeristy, Cardiff School of Biosciences, PO Box 915, Cardiff, UK, CF10 3TL.
| |
Collapse
|
33
|
Lebwohl M, Clark L, Levitt J. Therapy for head lice based on life cycle, resistance, and safety considerations. Pediatrics 2007; 119:965-74. [PMID: 17473098 DOI: 10.1542/peds.2006-3087] [Citation(s) in RCA: 76] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
Abstract
The timing of head lice maturation most favorable to their survival in the presence of anti-lice agents is the maximum time as an ovum (12 days) and the shortest possible time of maturing from newly hatched nymph to egg-laying adult (8.5 days). Pediculicides that are not reliably ovicidal (pyrethroids and lindane) require 2 to 3 treatment cycles to eradicate lice. Ovicidal therapies (malathion) require 1 to 2 treatments. Treatment with an agent to which there is genetic resistance is unproductive. In the United States, lice have become increasingly resistant to pyrethroids and lindane but not to malathion. Treatment with malathion has favorable efficacy and safety profiles and enables the immediate, safe return to school. Nit combing can be performed adjunctively. No-nit policies should be rendered obsolete.
Collapse
Affiliation(s)
- Mark Lebwohl
- Department of Dermatology, Mount Sinai School of Medicine, New York, NY 10029, USA
| | | | | |
Collapse
|
34
|
Abstract
Pediculosis capitis is common among children. Rapid and accurate detection is an underlying principle of effective control and the use of a fine-tooth comb in wet, conditioned hair is most sensitive. However, none of the available treatments are fully effective. Of the current pediculicides available over the counter in the UK, those based on malathion are more effective than pyrethroids. Carbaryl is likely to be the most effective insecticide but is only available on prescription. Wet combing with conditioner has proven to be as effective as some over-the-counter lotions for unsupervised use in the home. There are several promising candidates for new insecticidal actives that are likely to be highly effective for a new generation of pediculicides, as well as a variety of unconventional novel treatments.
Collapse
Affiliation(s)
- Nigel Hill
- Disease Control & Vector Biology Unit, Department of Infectious & Tropical Diseases, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.
| |
Collapse
|
35
|
Testud F, Grillet JP. Insecticides organophosphorés, carbamates, pyréthrinoïdes de synthèse et divers. ACTA ACUST UNITED AC 2007. [DOI: 10.1016/s1155-1925(07)71836-0] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
36
|
Hill N, Moor G, Cameron MM, Butlin A, Preston S, Williamson MS, Bass C. Single blind, randomised, comparative study of the Bug Buster kit and over the counter pediculicide treatments against head lice in the United Kingdom. BMJ 2005; 331:384-7. [PMID: 16085658 PMCID: PMC1184251 DOI: 10.1136/bmj.38537.468623.e0] [Citation(s) in RCA: 68] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
OBJECTIVE To compare the effectiveness of the Bug Buster kit with a single treatment of over the counter pediculicides for eliminating head lice. DESIGN Single blind, multicentre, randomised, comparative clinical study. SETTING Four counties in England and one county in Scotland. PARTICIPANTS 133 young people aged 2-15 years with head louse infestation: 56 were allocated to the Bug Buster kit and 70 to pediculicide treatment. INTERVENTIONS Home use of proprietary pediculicides (organophosphate or pyrethroid) or the Bug Buster kit. MAIN OUTCOME MEASURE Presence of head lice 2-4 days after end of treatment: day 5 for the pediculicides and day 15 for the Bug Buster kit. RESULTS The cure rate using the Bug Buster kit was significantly greater than that for the pediculicides (57% v 13%; relative risk 4.4, 95% confidence interval 2.3 to 8.5). Number needed to treat for the Bug Buster kit compared with the pediculicides was 2.26. CONCLUSION The Bug Buster kit was the most effective over the counter treatment for head louse infestation in the community when compared with pediculicides.
Collapse
Affiliation(s)
- N Hill
- Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London WC1E 7HT.
| | | | | | | | | | | | | |
Collapse
|
37
|
|
38
|
Prater MR, Blaylock BL, Holladay SD. Combined dermal exposure to permethrin and cis-urocanic acid suppresses the contact hypersensitivity response in C57BL/6N mice in an additive manner. JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY 2005; 78:29-34. [PMID: 15629246 DOI: 10.1016/j.jphotobiol.2004.09.004] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/01/2003] [Revised: 07/20/2004] [Accepted: 09/13/2004] [Indexed: 10/26/2022]
Abstract
Cutaneous exposure to the pyrethroid insecticide permethrin significantly suppresses contact hypersensitivity (CH) response to oxazolone in C57BL/6N mice. Additionally, cis-urocanic acid (cUCA), an endogenous cutaneous chromophore isomerized to its active form following exposure to ultraviolet radiation, modulates cell-mediated cutaneous immune responses. This study describes cutaneous immune alterations following combined topical permethrin and intradermal cUCA exposure. Female C57BL/6N mice were administered 5, 50 or 100 microg cUCA daily for 5 consecutive days. CH was then evaluated by the mouse ear swelling test (MEST) response to oxazolone. Decreased responses of 52.3%, 76.3% and 76.3%, respectively, as compared to controls were observed. Then, mice were co-exposed to 5 microg cUCA daily for 5 days and 1.5, 5, 15, or 25 microL permethrin, on either day 1, 3 or 5 of the cUCA treatment to evaluate combined immunomodulatory effects of the two chemicals, or cUCA daily for 5 days followed by permethrin on day 3, 5, or 7 after the last cUCA injection to demonstrate prolonged immunosuppressive effects. Two days after final treatment, mice were sensitized with oxazolone and MEST was performed. Mice receiving five cUCA injections and permethrin topically on cUCA injection day 1 showed up to 93.3% suppression of MEST compared to vehicle control. CH was suppressed by 87.5%, 86.6% and 74.2% in mice treated with 25 muL permethrin on days 3, 5 and 7 after cUCA, respectively, compared to vehicle control. Taken together, these data indicate co-exposure to cUCA and permethrin profoundly suppresses cell-mediated cutaneous immunity.
Collapse
Affiliation(s)
- M R Prater
- Department of Biomedical Sciences, Edward Via Virginia College of Osteopathic Medicine, 2265 Kraft Drive, Blacksburg, VA 24060, USA.
| | | | | |
Collapse
|
39
|
Tomalik-Scharte D, Lazar A, Meins J, Bastian B, Ihrig M, Wachall B, Jetter A, Tantcheva-Poór I, Mahrle G, Fuhr U. Dermal absorption of permethrin following topical administration. Eur J Clin Pharmacol 2005; 61:399-404. [PMID: 15947923 DOI: 10.1007/s00228-005-0932-7] [Citation(s) in RCA: 53] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2004] [Accepted: 03/14/2005] [Indexed: 10/25/2022]
Abstract
OBJECTIVE Permethrin is an insecticide used in the treatment of lice and scabies infections. Although its efficacy and safety have been well documented, pharmacokinetic data are sparse. The objective of this study was to determine the systemic exposure of permethrin and the duration of residence in the human body following topical administration. METHODS The study consisted of three parts. In six young healthy men (part 1), 50 ml of an ethanolic solution containing 215 mg permethrin (cis/trans: 25/75) was administered to the hair of the head. In another six young healthy men (part 2) and in six male or female scabies patients (part 3), 60 g of cream containing 3 g permethrin was administered to the skin of the whole body. Urine was collected up to 168 h post-dose. Urinary excretion of the main metabolite of permethrin, 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropane carboxylic acid, and its conjugates was measured using a gas chromatography/electron capture detection method. RESULTS Pharmacokinetics were similar in all study parts. The time of maximal urinary excretion rate was 12.3, 20.0 and 14.6 h, terminal elimination half-life was 32.7, 28.8 and 37.8 h and urinary recovery of the metabolite reached 0.35, 0.47 and 0.52 M percent of the permethrin dose, respectively, in parts 1, 2 and 3 (means). The treatment was well tolerated. CONCLUSIONS The extent of systemic exposure following external therapeutic administration of permethrin is very low compared with doses used for preclinical toxicity studies, and elimination is virtually complete after 1 week. These data provide the pharmacokinetic basis for the clinical safety of topical permethrin.
Collapse
Affiliation(s)
- D Tomalik-Scharte
- Department of Pharmacology, Clinical Pharmacology Unit, University of Cologne, Cologne, Germany
| | | | | | | | | | | | | | | | | | | |
Collapse
|
40
|
Affiliation(s)
- Imma Danés
- Fundació Institut Català de Farmacologia, Servicio de Farmacología Clínica, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
| | | |
Collapse
|
41
|
|
42
|
Les infestations par les poux de tête : Une mise à jour clinique. Paediatr Child Health 2004. [DOI: 10.1093/pch/9.9.653] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
43
|
Mills C, Cleary BJ, Gilmer JF, Walsh JJ. Inhibition of acetylcholinesterase by Tea Tree oil. J Pharm Pharmacol 2004; 56:375-9. [PMID: 15025863 DOI: 10.1211/0022357022773] [Citation(s) in RCA: 78] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
Abstract
Pediculosis is a widespread condition reported in schoolchildren. Treatment most commonly involves the physical removal of nits using fine-toothcombs and the chemical treatment of adult lice and eggs with topical preparations. The active constituents of these preparations frequently exert their effects through inhibition of acetylcholinesterase (AChE, EC 3.1.1.7). Increasing resistance to many preparations has led to the search for more effective treatments. Tea Tree oil, otherwise known as Melaleuca oil, has been added to several preparations as an alternative treatment of head lice infestations. In this study two major constituents of Tea Tree oil, 1,8-cineole and terpinen-4-ol, were shown to inhibit acetylcholinesterase at IC50 values (inhibitor concentrations required to give 50% inhibition) of 0.04 and 10.30 mM, respectively. Four samples of Tea Tree oil tested (Tisserand, Body Treats, Main Camp and Irish Health Culture Association Pure Undiluted) showed anticholinesterase activity at IC50 values of 0.05, 0.10, 0.08 and 0.11 microL mL(-1), respectively. The results supported the hypothesis that the insecticidal activity of Tea Tree oil was attributable, in part, to the anticholinesterase activity of Tea Tree oil.
Collapse
Affiliation(s)
- Clive Mills
- Department of Pharmacognosy, School of Pharmacy, Trinity College Dublin, College Street, Dublin 2, Ireland
| | | | | | | |
Collapse
|
44
|
Abstract
Current research on human louse biology has focused on the long-standing debate about speciation of head and body lice but using new tools of DNA and enzyme analysis. These studies have indicated that head and body lice from the same geographical zone may be more closely allied than insects inhabiting the same ecological niche in other regions. However, the majority of research over the past decade has involved clinical aspects including transmission, treatment, and the appearance and identification of resistant strains within populations of lice. Despite advances, there is a need for a better understanding of louse biology, as existing therapies fail and lice remain potential vectors of disease for millions of people.
Collapse
Affiliation(s)
- Ian F Burgess
- Insect Research & Development Limited, Cambridge Road, Fulbourn, Cambridge CB1 5EL, United Kingdom.
| |
Collapse
|
45
|
Lapeere H, Vander Stichele RH, Naeyaert JM. Evidence in the Treatment of Head Lice: Drowning in a Swamp of Reviews. Clin Infect Dis 2003; 37:1580-2. [PMID: 14614685 DOI: 10.1086/379614] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
|
46
|
Vander Stichele RH, Gyssels L, Bracke C, Meersschaut F, Blokland I, Wittouck E, Willems S, De Maeseneer J. Wet combing for head lice: feasibility in mass screening, treatment preference and outcome. J R Soc Med 2002. [PMID: 12091509 PMCID: PMC1279939 DOI: 10.1258/jrsm.95.7.348] [Citation(s) in RCA: 19] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
There is no scientific consensus on the best way to control head louse infestation in schoolchildren. A study was conducted to test the feasibility and acceptability of a screening campaign by wet combing and a community approach to head-louse control with home visits, and to explore parents' treatment preferences and treatment outcomes. A non-controlled intervention (advice on treatment options offered to all positive children) was nested within an epidemiological prevalence study. All children in three primary schools in Ghent, Belgium, were invited to take part in screening by wet combing (n=677, 3-11 years). Positive children were offered structural treatment advice, a home visit on day 7, and a check by wet combing on day 14. 83% of the children were screened. The prevalence of active infestation (living moving lice) was 13.0% in school 1 and 19.5% in school 3. In school 2, prevalence of signs of active and past infestation was 40.7%. A home visit was made to 58% of the positive children. 85% of the positive children were screened again on day 14. Wet combing was the most widely used treatment, followed by chemical treatment and a combination of the two. In school 1 and 3 51% were cured, and in school 2 24% became nit-free. A wet combing screening campaign and a community-oriented approach to head-louse control is feasible though resource-intensive. The prevalence of head lice was high and the cure rate was low, with either topical treatments or wet combing.
Collapse
Affiliation(s)
| | - L Gyssels
- Community Health Centres Brugse Poort, De Sleep and Botermarkt, Ghent,
Belgium
| | - C Bracke
- Community Health Centres Brugse Poort, De Sleep and Botermarkt, Ghent,
Belgium
| | - F Meersschaut
- Community Health Centres Brugse Poort, De Sleep and Botermarkt, Ghent,
Belgium
| | - I Blokland
- Community Health Centres Brugse Poort, De Sleep and Botermarkt, Ghent,
Belgium
| | - E Wittouck
- Department of Dermatology, Ghent University, Belgium
| | - S Willems
- Department of General Practice and Primary Health Care, Ghent University,
Belgium
| | - J De Maeseneer
- Department of General Practice and Primary Health Care, Ghent University,
Belgium
| |
Collapse
|
47
|
Vander Stichele RH, Gyssels L, Bracke C, Meersschaut F, Blokland I, Wittouck E, Willems S, De Maeseneer J. Wet Combing for Head Lice: Feasibility in Mass Screening, Treatment Preference and Outcome. Med Chir Trans 2002; 95:348-52. [PMID: 12091509 PMCID: PMC1279939 DOI: 10.1177/014107680209500707] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
There is no scientific consensus on the best way to control head louse infestation in schoolchildren. A study was conducted to test the feasibility and acceptability of a screening campaign by wet combing and a community approach to head-louse control with home visits, and to explore parents’ treatment preferences and treatment outcomes. A non-controlled intervention (advice on treatment options offered to all positive children) was nested within an epidemiological prevalence study. All children in three primary schools in Ghent, Belgium, were invited to take part in screening by wet combing (n=677, 3–11 years). Positive children were offered structural treatment advice, a home visit on day 7, and a check by wet combing on day 14. 83% of the children were screened. The prevalence of active infestation (living moving lice) was 13.0% in school 1 and 19.5% in school 3. In school 2, prevalence of signs of active and past infestation was 40.7%. A home visit was made to 58% of the positive children. 85% of the positive children were screened again on day 14. Wet combing was the most widely used treatment, followed by chemical treatment and a combination of the two. In school 1 and 3 51% were cured, and in school 2 24% became nit-free. A wet combing screening campaign and a community-oriented approach to head-louse control is feasible though resource-intensive. The prevalence of head lice was high and the cure rate was low, with either topical treatments or wet combing.
Collapse
|
48
|
Abstract
Evidence-based practice is the conscientious use of current best evidence in decision-making about care or the delivery of health services (National Institute for Public Health, 1996). Evidence-based health care is one aspect of the quality improvement activities of clinical governance as a main component of the programme of quality in the NHS (Hek, 2000). Practitioners working in clinical areas are therefore being required to deliver care that has been shown to be effective. (Playle, 2000).
Collapse
|
49
|
Affiliation(s)
- Dirk M Elston
- Department of Dermatology (MCHE-DD), Brooke Army Medical Center, Fort Sam Houston, TX 78234, USA
| |
Collapse
|
50
|
Abstract
Decisions must be made when assigning analgesics, and such decisions involve comparing efficacy and adverse effects. The rules for assessing efficacy by systematic review and by large clinical trials are becoming clearer all the time. It is known, for instance, that trials that are not randomized, are not double-blind, or are too small will exaggerate efficacy. These rules are relatively easy to apply to drug interventions, although there are glaring exceptions, such as in early intra-articular morphine studies. The rules may also be less easy to apply for analgesics available over-the-counter (OTC) if the drugs have not been studied in trials of high quality or if the OTC-recommended doses are below the doses studied in the trials. When there are at least 500 patients studied in trials of high quality, credible efficacy estimates for effective drugs can be derived; more patients are needed for less effective drugs. The number needed to treat and the number needed to harm can be used to compare the efficacy and safety of a treatment with placebo or with other treatments. A recent meta-analysis comparing the number needed to treat for paracetamol 1000 mg and paracetamol 600-650 mg in moderate to severe postoperative pain indicated that paracetamol 1000 mg is likely to be more effective than lower doses. Large data sets allow investigation into dose response, gender differences, and whether particular drugs work better for particular painful conditions. Purists would argue that databases of patient experience should not be used for these efficacy analyses. The rules on how to collect and use evidence on adverse effects are less clearly formulated than they are for efficacy. For safety at or above therapeutic dose, the rules of evidence-gathering are necessarily different, and randomized trials are rarely an adequate or sufficient source. Databases of patient experience, with all the caveats, may be the most reliable data from which to work.
Collapse
Affiliation(s)
- Henry J McQuay
- Pain Research, Nuffield Department of Anesthetics, University of Oxford, The Churchill Oxford Radcliffe Hospital, Headington, UK.
| | | | | |
Collapse
|